Generic drug may improve the effectiveness of cancer nanotherapies

Low doses of an inexpensive, FDA-approved hypertension medication may improve the results of nanotherapeutic approaches to cancer treatment. In a report in the early edition of Proceedings of the National Academy of Sciences, Massachusetts General Hospital (MGH) investigators describe experiments showing that the generic drug losartan, by modifying the network of collagen fibres that characterises most solid tumours, improved the effectiveness of two nanotherapeutics against several types of cancer...

Read the whole article on

More from